CONTEXT: Human embryonic stem cells (hESCs) differentiated toward β-cells and fetal human pancreatic islet cells resemble each other transcriptionally and are characterized by immaturity with a lack of glucose responsiveness, low levels of insulin content, and impaired proinsulin-to-insulin processing. However, their response to stimuli that promote functionality have not been compared. OBJECTIVE: The objective of the study was to evaluate the effects of our previous strategies for functional maturation developed in rodents in these two human models of β-cell immaturity and compare their responses. Design, Settings, Participants, and Interventions: In proof-of-principle experiments using either adenoviral-mediated overexpression of V-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA) or the physiologically driven path via thyroid hormone (T3) and human fetal islet-like cluster (ICC) functional maturity was evaluated. Then the effects of T3 were evaluated upon the functional maturation of hESCs differentiated toward β-cells. MAIN OUTCOME MEASURES: Functional maturation was evaluated by the following parameters: glucose responsiveness, insulin content, expression of the mature β-cell transcription factor MAFA, and proinsulin-to-insulin processing. RESULTS: ICCs responded positively to MAFA overexpression and T3 treatment as assessed by two different maturation parameters: increased insulin secretion at 16.8 mM glucose and increased proinsulin-to-insulin processing. In hESCs differentiated toward β-cells, T3 enhanced MAFA expression, increased insulin content (probably mediated by the increased MAFA), and increased insulin secretion at 16.8 mM glucose. CONCLUSION: T3 is a useful in vitro stimulus to promote human β-cell maturation as shown in both human fetal ICCs and differentiated hESCs. The degree of maturation induced varied in the two models, possibly due to the different developmental status at the beginning of the study.
CONTEXT: Human embryonic stem cells (hESCs) differentiated toward β-cells and fetal humanpancreatic islet cells resemble each other transcriptionally and are characterized by immaturity with a lack of glucose responsiveness, low levels of insulin content, and impaired proinsulin-to-insulin processing. However, their response to stimuli that promote functionality have not been compared. OBJECTIVE: The objective of the study was to evaluate the effects of our previous strategies for functional maturation developed in rodents in these two human models of β-cell immaturity and compare their responses. Design, Settings, Participants, and Interventions: In proof-of-principle experiments using either adenoviral-mediated overexpression of V-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA) or the physiologically driven path via thyroid hormone (T3) and human fetal islet-like cluster (ICC) functional maturity was evaluated. Then the effects of T3 were evaluated upon the functional maturation of hESCs differentiated toward β-cells. MAIN OUTCOME MEASURES: Functional maturation was evaluated by the following parameters: glucose responsiveness, insulin content, expression of the mature β-cell transcription factor MAFA, and proinsulin-to-insulin processing. RESULTS: ICCs responded positively to MAFA overexpression and T3 treatment as assessed by two different maturation parameters: increased insulin secretion at 16.8 mM glucose and increased proinsulin-to-insulin processing. In hESCs differentiated toward β-cells, T3 enhanced MAFA expression, increased insulin content (probably mediated by the increased MAFA), and increased insulin secretion at 16.8 mM glucose. CONCLUSION: T3 is a useful in vitro stimulus to promote human β-cell maturation as shown in both human fetal ICCs and differentiated hESCs. The degree of maturation induced varied in the two models, possibly due to the different developmental status at the beginning of the study.
Authors: K Hostens; D Pavlovic; Y Zambre; Z Ling; C Van Schravendijk; D L Eizirik; D G Pipeleers Journal: J Clin Invest Date: 1999-07 Impact factor: 14.808
Authors: Kevin A D'Amour; Anne G Bang; Susan Eliazer; Olivia G Kelly; Alan D Agulnick; Nora G Smart; Mark A Moorman; Evert Kroon; Melissa K Carpenter; Emmanuel E Baetge Journal: Nat Biotechnol Date: 2006-10-19 Impact factor: 54.908
Authors: C Aguayo-Mazzucato; A Koh; I El Khattabi; W-C Li; E Toschi; A Jermendy; K Juhl; K Mao; G C Weir; A Sharma; S Bonner-Weir Journal: Diabetologia Date: 2010-12-29 Impact factor: 10.122
Authors: Evert Kroon; Laura A Martinson; Kuniko Kadoya; Anne G Bang; Olivia G Kelly; Susan Eliazer; Holly Young; Mike Richardson; Nora G Smart; Justine Cunningham; Alan D Agulnick; Kevin A D'Amour; Melissa K Carpenter; Emmanuel E Baetge Journal: Nat Biotechnol Date: 2008-02-20 Impact factor: 54.908
Authors: Alireza Rezania; Jennifer E Bruin; Michael J Riedel; Majid Mojibian; Ali Asadi; Jean Xu; Rebecca Gauvin; Kavitha Narayan; Francis Karanu; John J O'Neil; Ziliang Ao; Garth L Warnock; Timothy J Kieffer Journal: Diabetes Date: 2012-06-27 Impact factor: 9.337
Authors: Cristina Aguayo-Mazzucato; Terence B Lee; Michelle Matzko; Amanda DiIenno; Habib Rezanejad; Preeti Ramadoss; Thomas Scanlan; Ann Marie Zavacki; P Reed Larsen; Anthony Hollenberg; Clark Colton; Arun Sharma; Susan Bonner-Weir Journal: Diabetes Date: 2018-04-06 Impact factor: 9.461
Authors: Elisa Corritore; Yong-Syu Lee; Valentina Pasquale; Daniela Liberati; Mei-Ju Hsu; Catherine Anne Lombard; Patrick Van Der Smissen; Amedeo Vetere; Susan Bonner-Weir; Lorenzo Piemonti; Etienne Sokal; Philippe A Lysy Journal: Stem Cells Transl Med Date: 2016-07-12 Impact factor: 6.940
Authors: Shelley E Harris; Miles J De Blasio; Melissa A Davis; Amy C Kelly; Hailey M Davenport; F B Peter Wooding; Dominique Blache; David Meredith; Miranda Anderson; Abigail L Fowden; Sean W Limesand; Alison J Forhead Journal: J Physiol Date: 2017-03-13 Impact factor: 5.182